Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dr1-associated corepressor (DRAP1) is a nuclear protein encoded by the DRAP1 gene, functioning as a corepressor of transcription. DRAP1 forms a complex with DR1, interacting with the TATA-binding protein (TBP) in eukaryotes. This complex selectively represses transcription initiation by preventing the entry of essential transcription factors (TFIIA, TFIIB) into the preinitiation complex, thereby regulating gene expression. This interaction is critical for stabilizing TBP-DR1-DNA complexes and modulating RNA polymerase II and III activities. Both DR1 and DRAP1 contain histone-fold motifs essential for their interaction and repression function. DRAP1 plays a central role in global transcriptional repression and cell viability, with dysfunction implicated in various diseases including some cancers
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dr1-associated corepressor (DRAP1).